Literature DB >> 1954070

Selective effects of low doses of apomorphine on spatiotemporal contrast sensitivity in healthy volunteers: a double-blind placebo-controlled study.

O Blin1, D Mestre, G Masson, G Serratrice.   

Abstract

1. Apomorphine (1 and 5 micrograms kg-1) and placebo were given to nine normal volunteers, using a Latin-square design and double-blind procedures. The visual perception of static and moving patterns (static and motion contrast sensitivity) was evaluated before and 15 min after the dose administration. 2. Apomorphine (1 and 5 micrograms kg-1), as compared with placebo, led to a significant overall reduction of the visual perception of movement. This effect was dose-related, and apomorphine (5 micrograms kg-1) induced a more pronounced decrease in the visual perception of movement than apomorphine (1 microgram kg-1). With apomorphine (5 micrograms kg-1), the reduction was more pronounced for low spatial frequencies, and was linearly inversely correlated to the spatial frequency for a temporal frequency of 3 Hz. Finally, no significant effect of apomorphine was observed for sensitivity to static patterns. 3. Several non exclusive hypotheses may be suggested: The effects of apomorphine may result from stimulation of retinal D1- and/or D2-dopaminergic receptors. Apomorphine may increase the surround inhibition of ganglion cells' receptive-fields. This modification of the centre-surround balance may explain the decrease in contrast sensitivity for low spatial frequencies. The specific effects of apomorphine on the visual perception of movement support the hypothesis that apomorphine preferentially affects the magnocellular pathway which mediates sensitivity to moving patterns.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1954070      PMCID: PMC1368629          DOI: 10.1111/j.1365-2125.1991.tb03950.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  35 in total

1.  The contrast sensitivity of retinal ganglion cells of the cat.

Authors:  C Enroth-Cugell; J G Robson
Journal:  J Physiol       Date:  1966-12       Impact factor: 5.182

2.  Effects of dopamine and its agonists and antagonists on the receptive field properties of ganglion cells in the rabbit retina.

Authors:  R J Jensen; N W Daw
Journal:  Neuroscience       Date:  1986-03       Impact factor: 3.590

3.  Contrast sensitivity in Parkinson's disease.

Authors:  C Bulens; J D Meerwaldt; G J van der Wildt; C J Keemink
Journal:  Neurology       Date:  1986-08       Impact factor: 9.910

4.  Possible indication of dopaminergic blockade in man by electroretinography.

Authors:  V Filip; J Balík
Journal:  Int Pharmacopsychiatry       Date:  1978

5.  Dopaminergic drugs improve human visual contrast sensitivity.

Authors:  L Domenici; C Trimarchi; M Piccolino; A Fiorentini; L Maffei
Journal:  Hum Neurobiol       Date:  1985

6.  Dopamine receptors are located on rods in bovine retina.

Authors:  M R Brann; W S Young
Journal:  Neurosci Lett       Date:  1986-09-12       Impact factor: 3.046

7.  Dopaminergic neurons in the human retina.

Authors:  J M Frederick; M E Rayborn; A M Laties; D M Lam; J G Hollyfield
Journal:  J Comp Neurol       Date:  1982-09-01       Impact factor: 3.215

8.  Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects.

Authors:  S Nightingale; K W Mitchell; J W Howe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-11       Impact factor: 10.154

9.  Action of iontophoretically applied dopamine on cat retinal ganglion cells.

Authors:  P Thier; V Alder
Journal:  Brain Res       Date:  1984-01-30       Impact factor: 3.252

10.  Pharmacological differences between the D-2 autoreceptor and the D-1 dopamine receptor in rabbit retina.

Authors:  M L Dubocovich; N Weiner
Journal:  J Pharmacol Exp Ther       Date:  1985-06       Impact factor: 4.030

View more
  2 in total

1.  GABA-ergic control of visual perception in healthy volunteers: effects of midazolam, a benzodiazepine, on spatio-temporal contrast sensitivity.

Authors:  O Blin; D Mestre; O Paut; J L Vercher; C Audebert
Journal:  Br J Clin Pharmacol       Date:  1993-08       Impact factor: 4.335

2.  Schizophrenia and the eye.

Authors:  Steven M Silverstein; Richard Rosen
Journal:  Schizophr Res Cogn       Date:  2015-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.